Cravens & Co Advisors’s Abbott ABT Stock Holding History

Cravens & Co Advisors’s Portfolio ABT Stock Details ABT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-9,117	Closed	-$936K	–	68
2026 Q1	$936K	Buy	9,117 +555	+6%	+$62.7K	0.61%	37
2025 Q4	$1.06M	Sell	8,562 -578	-6%	-$73.6K	0.7%	33
2025 Q3	$1.22M	Buy	9,140 +515	+6%	+$67.6K	0.84%	27
2025 Q2	$1.17M	Sell	8,625 -21	-0.2%	-$2.77K	0.88%	28
2025 Q1	$1.15M	Sell	8,646 -293	-3%	-$37.3K	0.89%	25
2024 Q4	$1.01M	Buy	8,939 +145	+2%	+$16.8K	0.77%	28
2024 Q3	$1M	Sell	8,794 -886	-9%	-$97.2K	0.77%	27
2024 Q2	$1.01M	Buy	9,680 +2,427	+33%	+$257K	0.75%	31
2024 Q1	$824K	Buy	7,253 +344	+5%	+$39.4K	0.68%	31
2023 Q4	$760K	Sell	6,909 -296	-4%	-$29.6K	0.66%	37
2023 Q3	$698K	Buy	7,205 +118	+2%	+$12.4K	0.66%	37
2023 Q2	$773K	Sell	7,087 -25	-0.4%	-$2.67K	0.71%	34
2023 Q1	$720K	Buy	7,112 +170	+2%	+$17.9K	0.67%	33
2022 Q4	$762K	Buy	+6,942	New	+$719K	0.71%	28

Other funds holding ABT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Cravens & Co Advisors's ABT Position: Q2 2026 in Review

Cravens & Co Advisors sold out of Abbott (ABT) in Q2 2026, closing a stake of 9,117 shares — an estimated $936K sold.

Cravens & Co Advisors first reported a position in ABT in Q4 2022 and held it in 14 quarters. The position peaked at $1.22M in Q3 2025. 2,968 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

Cravens & Co Advisors reported no remaining Abbott position as of Q2 2026 after selling out during the quarter.
Cravens & Co Advisors sold 9,117 Abbott shares in Q2 2026, an estimated $936K.
Cravens & Co Advisors first reported a position in Abbott in Q4 2022 and held it in 14 quarters.
Cravens & Co Advisors's Abbott position peaked at $1.22M in Q3 2025.
2,968 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on Cravens & Co Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.